{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:29:34Z","timestamp":1794072574427,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation Youth Fund","award":["22104015"],"award-info":[{"award-number":["22104015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"DOI":"10.1038\/s41540-026-00663-w","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:45:27Z","timestamp":1773423927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrated multi-omics and single-cell analysis reveals CDKN2A-mediated cuproptosis mechanisms driving thyroid carcinoma progression"],"prefix":"10.1038","volume":"12","author":[{"given":"Jukai","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"663_CR1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen, D. W., Lang, B. H. H., McLeod, D. S. A., Newbold, K. & Haymart, M. R. Thyroid cancer. Lancet 401, 1531\u20131544 (2023).","journal-title":"Lancet"},{"key":"663_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fendo.2020.00082","volume":"11","author":"D Laha","year":"2020","unstructured":"Laha, D., Nilubol, N. & Boufraqech, M. New therapies for advanced thyroid cancer. Front. Endocrinol. 11, 82 (2020).","journal-title":"Front. Endocrinol."},{"key":"663_CR3","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/ijc.33690","volume":"149","author":"F Nabhan","year":"2021","unstructured":"Nabhan, F., Dedhia, P. H. & Ringel, M. D. Thyroid cancer, recent advances in diagnosis and therapy. Int. J. Cancer 149, 984\u2013992 (2021).","journal-title":"Int. J. Cancer"},{"key":"663_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ecl.2018.10.002","volume":"48","author":"CD Seib","year":"2019","unstructured":"Seib, C. D. & Sosa, J. A. Evolving understanding of the epidemiology of thyroid cancer. Endocrinol. Metab. Clin. North Am. 48, 23\u201335 (2019).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"663_CR5","first-page":"10","volume":"1","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. Optimized dynamic network biomarker deciphers a high-resolution heterogeneity within thyroid cancer molecular subtypes. Med. Res. 1, 10\u201331 (2025).","journal-title":"Med. Res."},{"key":"663_CR6","doi-asserted-by":"publisher","first-page":"1610558","DOI":"10.3389\/pore.2022.1610558","volume":"28","author":"X Chen","year":"2022","unstructured":"Chen, X., Hu, G., Xiong, L. & Xu, Q. Relationships of cuproptosis-related genes with clinical outcomes and the tumour immune microenvironment in hepatocellular carcinoma. Pathol. Oncol. Res. 28, 1610558 (2022).","journal-title":"Pathol. Oncol. Res."},{"key":"663_CR7","doi-asserted-by":"publisher","first-page":"1074981","DOI":"10.3389\/fgene.2022.1074981","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation. Front. Genet. 13, 1074981 (2022).","journal-title":"Front. Genet."},{"key":"663_CR8","first-page":"397","volume":"1","author":"X Ke","year":"2025","unstructured":"Ke, X. et al. Cloud-based GWAS platform: an innovative solution for efficient acquisition and analysis of genomic data. Med. Res. 1, 397\u2013411 (2025).","journal-title":"Med. Res."},{"key":"663_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41392-022-01014-x","volume":"7","author":"S-R Li","year":"2022","unstructured":"Li, S.-R., Bu, L.-L. & Cai, L. Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway. Signal Transduct. Target. Ther. 7, 158 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"663_CR10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254\u20131261 (2022).","journal-title":"Science"},{"key":"663_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41422-022-00653-7","volume":"32","author":"D Tang","year":"2022","unstructured":"Tang, D., Chen, X. & Kroemer, G. Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Res. 32, 417\u2013418 (2022).","journal-title":"Cell Res."},{"key":"663_CR12","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1007\/s00268-013-2164-9","volume":"37","author":"S Basu","year":"2013","unstructured":"Basu, S. et al. Heavy and trace metals in carcinoma of the gallbladder. World J. Surg. 37, 2641\u20132646 (2013).","journal-title":"World J. Surg."},{"key":"663_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01732-y","volume":"22","author":"J Xie","year":"2023","unstructured":"Xie, J., Yang, Y., Gao, Y. & He, J. Cuproptosis: mechanisms and links with cancers. Mol. Cancer 22, 46 (2023).","journal-title":"Mol. Cancer"},{"key":"663_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen, L., Min, J. & Wang, F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct. Target. Ther. 7, 378 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"663_CR15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41423-022-00866-1","volume":"19","author":"Y Wang","year":"2022","unstructured":"Wang, Y., Zhang, L. & Zhou, F. Cuproptosis: a new form of programmed cell death. Cell. Mol. Immunol. 19, 867\u2013868 (2022).","journal-title":"Cell. Mol. Immunol."},{"key":"663_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53560-9","volume":"14","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Identification and validation of a copper homeostasis-related gene signature for the predicting prognosis of breast cancer patients via integrated bioinformatics analysis. Sci. Rep. 14, 3141 (2024).","journal-title":"Sci. Rep."},{"key":"663_CR17","doi-asserted-by":"publisher","first-page":"1188725","DOI":"10.3389\/fphar.2023.1188725","volume":"14","author":"S Zhao","year":"2023","unstructured":"Zhao, S. et al. Integrated machine learning and bioinformatic analyses used to construct a copper-induced cell death-related classifier for prognosis and immunotherapeutic response of hepatocellular carcinoma patients. Front. Pharmacol. 14, 1188725 (2023).","journal-title":"Front. Pharmacol."},{"key":"663_CR18","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.2174\/0113862073333880240819105537","volume":"28","author":"J Cao","year":"2025","unstructured":"Cao, J. et al. A novel cuproptosis-related gene signature predicts prognosis in papillary thyroid carcinoma patients. Comb. Chem. High Throughput Screen. 28, 2463\u20132476 (2025).","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"663_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03630-1","volume":"20","author":"C Yan","year":"2022","unstructured":"Yan, C., Niu, Y., Ma, L., Tian, L. & Ma, J. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma. J. Transl. Med. 20, 452 (2022).","journal-title":"J. Transl. Med."},{"key":"663_CR20","doi-asserted-by":"publisher","first-page":"1081952","DOI":"10.3389\/fphar.2022.1081952","volume":"13","author":"Y Li","year":"2023","unstructured":"Li, Y. & Zeng, X. A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma. Front. Pharmacol. 13, 1081952 (2023).","journal-title":"Front. Pharmacol."},{"key":"663_CR21","first-page":"1","volume":"2022","author":"B Jiang","year":"2022","unstructured":"Jiang, B. et al. Database mining detected a cuproptosis-related prognostic signature and a related regulatory axis in breast cancer. Dis. Markers 2022, 1\u201322 (2022).","journal-title":"Dis. Markers"},{"key":"663_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040132","volume":"103","author":"J Chen","year":"2024","unstructured":"Chen, J., Cao, W., Li, Y. & Zhu, J. Comprehensive analysis of the expression level, prognostic value, and immune infiltration of cuproptosis-related genes in human breast cancer. Medicine 103, e40132 (2024).","journal-title":"Medicine"},{"key":"663_CR23","doi-asserted-by":"publisher","first-page":"2249217","DOI":"10.1080\/16078454.2023.2249217","volume":"28","author":"H Wang","year":"2023","unstructured":"Wang, H. et al. Identification and study of cuproptosis-related genes in prognostic model of multiple myeloma. Hematology 28, 2249217 (2023).","journal-title":"Hematology"},{"key":"663_CR24","first-page":"4074","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu, H. Pan-cancer profiles of the cuproptosis gene set. Am. J. Cancer Res. 12, 4074\u20134081 (2022).","journal-title":"Am. J. Cancer Res."},{"key":"663_CR25","doi-asserted-by":"publisher","first-page":"925618","DOI":"10.3389\/fimmu.2022.925618","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in hepatocellular carcinoma. Front. Immunol. 13, 925618 (2022).","journal-title":"Front. Immunol."},{"key":"663_CR26","doi-asserted-by":"publisher","first-page":"1269478","DOI":"10.3389\/fmolb.2023.1269478","volume":"10","author":"J Qin","year":"2023","unstructured":"Qin, J. et al. Identification of cuproptosis-related biomarkers and analysis of immune infiltration in allograft lung ischemia-reperfusion injury. Front. Mol. Biosci. 10, 1269478 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"663_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-50039-x","volume":"13","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Comprehensive analysis of the potential biological significance of cuproptosis-related gene LIPT2 in pan-cancer prognosis and immunotherapy. Sci. Rep. 13, 22910 (2023).","journal-title":"Sci. Rep."},{"key":"663_CR28","doi-asserted-by":"publisher","first-page":"1117164","DOI":"10.3389\/fonc.2023.1117164","volume":"13","author":"Q Zhao","year":"2023","unstructured":"Zhao, Q. & Qi, T. The implications and prospect of cuproptosis-related genes and copper transporters in cancer progression. Front. Oncol. 13, 1117164 (2023).","journal-title":"Front. Oncol."},{"key":"663_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jid.2022.07.016","volume":"143","author":"IZM Kreuger","year":"2023","unstructured":"Kreuger, I. Z. M., Slieker, R. C., van Groningen, T. & van Doorn, R. Therapeutic strategies for targeting CDKN2A loss in melanoma. J. Investig. Dermatol. 143, 18\u201325.e1 (2023).","journal-title":"J. Investig. Dermatol."},{"key":"663_CR30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s40291-022-00610-5","volume":"26","author":"S Tsuriel","year":"2022","unstructured":"Tsuriel, S., Hannes, V., Hasona, A., Raz, M. & Hershkovitz, D. Digital PCR-based method for detecting CDKN2A loss in brain tumours. Mol. Diagn. Ther. 26, 689\u2013698 (2022).","journal-title":"Mol. Diagn. Ther."},{"key":"663_CR31","doi-asserted-by":"publisher","first-page":"117907","DOI":"10.1016\/j.jep.2024.117907","volume":"325","author":"H Chen","year":"2024","unstructured":"Chen, H., Deng, J., Hou, T.-W. & Shan, Y.-Q. Villosol reverses 5-FU resistance in colorectal cancer by inhibiting the CDKN2A gene regulated TP53-PI3K\/Akt signaling axis. J. Ethnopharmacol. 325, 117907 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"663_CR32","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","volume":"21","author":"A Marabelle","year":"2020","unstructured":"Marabelle, A. et al. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. Lancet Oncol. 21, 1353\u20131365 (2020).","journal-title":"Lancet Oncol."},{"key":"663_CR33","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1007\/s10528-024-10767-9","volume":"63","author":"Z Guan","year":"2024","unstructured":"Guan, Z., Wang, H. & Tian, M. A cuproptosis-related gene signature as a prognostic biomarker in thyroid cancer based on transcriptomics. Biochem. Genet. 63, 1584\u20131604 (2024).","journal-title":"Biochem. Genet."},{"key":"663_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.dld.2019.08.012","volume":"52","author":"Y Liu","year":"2020","unstructured":"Liu, Y., Yin, L., Chen, C., Zhang, X. & Wang, S. Long non-coding RNA GAS5 inhibits migration and invasion in gastric cancer via interacting with p53 protein. Digest. Liver Dis. 52, 331\u2013338 (2020).","journal-title":"Digest. Liver Dis."},{"key":"663_CR35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s13577-020-00331-z","volume":"33","author":"W Huang","year":"2020","unstructured":"Huang, W. et al. LncRNA GAS5-AS1 inhibits glioma proliferation, migration, and invasion via miR-106b-5p\/TUSC2 axis. Hum. Cell 33, 416\u2013426 (2020).","journal-title":"Hum. Cell"},{"key":"663_CR36","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.7150\/jca.56218","volume":"12","author":"L Zhu","year":"2021","unstructured":"Zhu, L. et al. LncRNA GAS5 inhibits invasion and migration of lung cancer through influencing EMT process. J. Cancer 12, 3291\u20133298 (2021).","journal-title":"J. Cancer"},{"key":"663_CR37","first-page":"1285","volume":"26","author":"W Li","year":"2018","unstructured":"Li, W., Zhao, W., Lu, Z., Zhang, W. & Yang, X. Long noncoding RNA GAS5 promotes proliferation, migration, and invasion by regulation of miR-301a in esophageal cancer. Oncol. Res. Featur. Preclin. Clin. Cancer Ther. 26, 1285\u20131294 (2018).","journal-title":"Oncol. Res. Featur. Preclin. Clin. Cancer Ther."},{"key":"663_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3892\/ijmm.2024.5423","volume":"54","author":"W Zhao","year":"2024","unstructured":"Zhao, W., Wang, W., Zhu, Y., Lv, Z. & Xu, W. Molecular mechanisms and clinicopathological characteristics of inhibin \u03b2A in thyroid cancer metastasis. Int. J. Mol. Med. 54, 99 (2024).","journal-title":"Int. J. Mol. Med."},{"key":"663_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13046-021-01964-0","volume":"40","author":"X Zheng","year":"2021","unstructured":"Zheng, X. et al. circPVT1 regulates medullary thyroid cancer growth and metastasis by targeting miR-455-5p to activate CXCL12\/CXCR4 signaling. J. Exp. Clin. Cancer Res. 40, 157 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"663_CR40","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.biopha.2017.06.075","volume":"93","author":"X Lin","year":"2017","unstructured":"Lin, X., Chang, W., Wang, Y., Tian, M. & Yu, Z. SRPX2, an independent prognostic marker, promotes cell migration and invasion in hepatocellular carcinoma. Biomed. Pharmacother. 93, 398\u2013405 (2017).","journal-title":"Biomed. Pharmacother."}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00663-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00663-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00663-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:56:38Z","timestamp":1777503398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00663-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1038\/s41540-026-00663-w","relation":{},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}